Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-906 and Itraconazole Interaction Study in Healthy Subjects
NCT03161405Phase 1Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Jun 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of trazpiroben in gastroparesis, sponsored by Millennium Pharmaceuticals. Primary endpoints: Maximum Observed Plasma Concentration at 48 hours and Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration at 48 hours. Started Jun 2017; status: completed.
02
Drugs
trazpiroben
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT03161405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03161405.